Health

The latest weekly reports from the Acute Respiratory Infections Surveillance System indicate an increase in incidence.morbidity

On May 5, 2023, the World Health Organization ( WHO ) declared the end of the international health emergency due to Covid-19 . However, that summer we again experienced an increase in the incidence of the disease in Spain , although it began to be detected later than this year, at the beginning of August, when there were 99.4 cases per 100,000 inhabitants. Where are we now? The latest weekly reports from the Acute Respiratory Infections Surveillance System ( Sivira ) estimate an increase in the incidence of Covid-19: 107.7 cases per 100,000 inhabitants (previous week: 85.4 cases per 100,000 inhabitants; previous week: 57.7 cases), according to data from June 3 to June 9. Are these numbers a cause for concern? Are they announcing the next wave? The experts interviewed (doctors, pharmacists and microbiologists) sound the alarm in due course .

Pages: 1 2 3

Finding an approach to small cell lung and liver cancer is the goal of two new projects involving more than 50 research groups.

Responsible for the Spanish Association for Cancer Control (AECC) presented this morning two research projects on cancer with low survival rates that will receive a total of 18 million euros from the AECC 70{45be94c78c821f0f73f172cd5ac07f746796a7755bae6ebdb1cb91efc3b302a3} Survival Challenge Challenge Aid program , aimed at achieving this goal. percent in 2030. percent.

The first of the awarded projects is Sosclc-AECC. Small Cell Lung Cancer. From biological networks to personalized therapies . The project will be funded with 10 million euros for five years. It is led by Luis Paz-Ares of the Hospital Research Institute of October 12 Hospital in Madrid and Marcos Malumbres of the VHIO in Barcelona, who will coordinate 40 research teams in 15 provinces.

Pages: 1 2 3

Infectious erythema is an infection caused by human parvovirus (B19), the symptom of which can be a rash on the cheeks.

Since the beginning of April, 40 outbreaks of the so-called “slap virus”, also called parvovirus or infectious erythema, have been reported in Catalonia, a highly contagious disease among children, although not serious.

Infectious erythema is an infection caused by human parvovirus (B19), the symptom of which can be a rash on the cheeks, hence the name “slap virus”.

Pages: 1 2 3

Biofabri and TBVI sign an agreement with the European Commission to accelerate the final development of the MTBVAC vaccine.

Tuberculosis affects 10 million people each, and drug-resistant tuberculosis is a growing problem, with more than 400,000 new cases and more than 150,000 deaths each year. Finding a defense against this infection is no easy task.

Zenda l Group, through its subsidiary Biofabri, and TBVI (a European non-profit foundation that promotes the discovery and development of new, safe and effective TB vaccines that are accessible and affordable for all people) have signed a contract with the European Executive Agency for Health and Digital Agenda (HaDEA) under the EU4Health program to accelerate the final development of the MTBVAC vaccine.

Pages: 1 2 3

“Semaglutide is not part of the WHO recommended treatments for diabetes because of its current high cost. The price barrier makes these products unsuitable for public health.”

The World Health Organization (WHO) this Thursday issued a warning about counterfeit semaglutide, a medication used to treat type 2 diabetes and weight loss.

According to WHO, the warning concerns three counterfeit batches of products from the semaglutide class (specific brand name Ozempic ) that were detected in Brazil in October 2023, in the United Kingdom and Northern Ireland in October 2023, and in the United States in December 2023.

Pages: 1 2 3